- Home
- INKT vs MDAI Comparison
INKT vs MDAI Comparison
Compare INKT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- MDAI
- Stock Information
- Founded
- INKT 2017
- MDAI 2013
- Country
- INKT United States
- MDAI United States
- Employees
- INKT N/A
- MDAI N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- MDAI Medical/Dental Instruments
- Sector
- INKT Health Care
- MDAI Health Care
- Exchange
- INKT Nasdaq
- MDAI Nasdaq
- Market Cap
- INKT 33.6M
- MDAI 27.8M
- IPO Year
- INKT 2021
- MDAI N/A
- Fundamental
- Price
- INKT $7.25
- MDAI $1.24
- Analyst Decision
- INKT Strong Buy
- MDAI Strong Buy
- Analyst Count
- INKT 2
- MDAI 2
- Target Price
- INKT $37.50
- MDAI $4.75
- AVG Volume (30 Days)
- INKT 5.5K
- MDAI 436.0K
- Earning Date
- INKT 05-13-2025
- MDAI 05-06-2025
- Dividend Yield
- INKT N/A
- MDAI N/A
- EPS Growth
- INKT N/A
- MDAI N/A
- EPS
- INKT N/A
- MDAI N/A
- Revenue
- INKT N/A
- MDAI $29,581,000.00
- Revenue This Year
- INKT N/A
- MDAI N/A
- Revenue Next Year
- INKT N/A
- MDAI $102.58
- P/E Ratio
- INKT N/A
- MDAI N/A
- Revenue Growth
- INKT N/A
- MDAI 63.83
- 52 Week Low
- INKT $4.56
- MDAI $0.82
- 52 Week High
- INKT $13.79
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- INKT 39.62
- MDAI 41.89
- Support Level
- INKT $7.23
- MDAI $1.18
- Resistance Level
- INKT $8.59
- MDAI $1.28
- Average True Range (ATR)
- INKT 0.72
- MDAI 0.10
- MACD
- INKT -0.10
- MDAI 0.02
- Stochastic Oscillator
- INKT 0.66
- MDAI 50.00
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.